Edwards Lifesciences Corporation (EW)

Last Closing Price: 86.19 (2025-12-05)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Edwards Lifesciences Corporation (EW) had Net Income of $291.10M for the most recently reported fiscal quarter, ending 2025-09-30.

Figures for fiscal quarter ending 2025-09-30
Income Statement Financials
$1.55B
Net Income
$291.10M
$345.20M
$1.21B
$1.25B
$307.10M
$41.30M
$348.40M
$348.40M
$292.30M
$292.30M
$290.30M
$292.30M
$307.10M
$346.30M
584.70M
585.70M
$0.50
$0.50
Balance Sheet Financials
$6.36B
$1.74B
$6.91B
$13.27B
$1.59B
$598.20M
$1.48B
$3.07B
$10.21B
$7.31B
$10.21B
580.70M
Cash Flow Statement Financials
$1.14B
$-514.60M
$-945.40M
$3.06B
$2.69B
$-364.00M
$118.90M
--
--
Fundamental Metrics & Ratios
4.00
--
--
0.06
0.06
77.77%
19.77%
19.77%
--
22.43%
18.74%
$981.50M
--
--
--
0.12
0.30
1.74
51.74
2.86%
4.00%
2.20%
2.71%
$17.57
$1.68
$1.95